Replies to post #117197 on Amarin Corp Plc (AMRN)

[VuBru]

Kiwi - I have been involved in drug patent challenges. I beleive that whether or not generic high purity EPA products violate the V patents depends on the wording AMRN used in the patents. The patents I have seen list a range of doses rather than a single dose (to cover themselves broadly). So, if the ARMN patents for V said "EPA between 80 - 100% pure, with less than 10% DHA", all high purity EPA currently sold as DS would violate the patents. I have not read the patents, so do not know if this is the case though.

[sts66]

EE-EPA is NCE - any DS that contains it has the identical active ingredient as V - this ain't rocket science. Amount of DHA doesn't matter - that goes to patents, not whether EE-EPA is a drug or not.